<SEC-DOCUMENT>0001209191-22-053123-index.html : 20221007
<SEC-HEADER>0001209191-22-053123.hdr.sgml : 20221007
<ACCEPTANCE-DATETIME>20221007163936
ACCESSION NUMBER:		0001209191-22-053123
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20221005
FILED AS OF DATE:		20221007
DATE AS OF CHANGE:		20221007

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Haddadin Yezan Munther
		CENTRAL INDEX KEY:			0001718004

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37759
		FILM NUMBER:		221301169

	MAIL ADDRESS:	
		STREET 1:		ZAHRAN STREET, 7TH CIRCLE ZAHRAN PLAZA
		STREET 2:		4TH FLOOR, PO BOX 142904
		CITY:			AMMAN
		STATE:			M2
		ZIP:			11844

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Outlook Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001649989
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				383982704
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0930

	BUSINESS ADDRESS:	
		STREET 1:		485 ROUTE 1 SOUTH
		STREET 2:		BUILDING F, SUITE 320
		CITY:			ISELIN
		STATE:			NJ
		ZIP:			08830
		BUSINESS PHONE:		6096193990

	MAIL ADDRESS:	
		STREET 1:		485 ROUTE 1 SOUTH
		STREET 2:		BUILDING F, SUITE 320
		CITY:			ISELIN
		STATE:			NJ
		ZIP:			08830

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Oncobiologics, Inc.
		DATE OF NAME CHANGE:	20150804
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>doc4.xml
<DESCRIPTION>FORM 4 SUBMISSION
<TEXT>
Document 1 - file: doc4.html

Document 1 - RAW XML: doc4.xml

</DOCUMENT>
</SEC-DOCUMENT>